Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells

DNA Repair

Volumn 3, Issue 2, 2004, Pages 135-143

  Lan, Li ^a   Hayashi, Tsuyuko ^a   Rabeya, Rokshana M ^a   Nakajima, Satoshi ^a   Kanno, Shin Ichiro ^a   Takao, Masashi ^a   Matsunaga, Tsukasa ^b   Yoshino, Masafumi ^c   Ichikawa, Minoru ^c   Te Riele, Hein ^d   Tsuchiya, Shigeru ^a   Tanaka, Kiyoji ^c   Yasui, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CDDP; ERCC1; MSH2; Nucleotide excision repair; RNAi

Indexed keywords

CELL EXTRACT; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PROTEIN; PROTEIN MSH2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS7; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG SENSITIVITY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; MISMATCH REPAIR; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

MAMMALIA; RODENTIA;

EID: 0347360230     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2003.10.005     Document Type: Article

References (48)

1. Sijbers A.M., de Laat W.L., Ariza R.R., Biggerstaff M., Wei Y.F., Moggs J.G., Carter K.C., Shell B.K., Evans E., de Jong M.C., Rademakers S., de Rooij J., Jaspers N.G., Hoeijmakers J.H., Wood R.D. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell. 86:1996;811-822.
2. Bessho T., Sancar A., Thompson L.H., Thelen M.P. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J. Biol. Chem. 272:1997;3833-3837.
3. Biggerstaff M., Szymkowski D.E., Wood R.D. Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J. 12:1993;3685-3692.
4. Gaillard P.H., Wood R.D. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair. Nucl. Acids Res. 29:2001;872-879.
5. De Silva I.U., McHugh P.J., Clingen P.H., Hartley J.A. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol. 20:2000;7980-7990.
6. McHugh P.J., Spanswick V.J., Hartley J.A. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2:2001;483-490.
7. Wang X., Peterson C.A., Zheng H., Nairn R.S., Legerski R.J., Li L. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol. Cell. Biol. 21:2001;713-720.
8. Zheng H., Wang X., Warren A.J., Legerski R.J., Nairn R.S., Hamilton J.W., Li L. Nucleotide excision repair- and polymerase-mediated error-prone removal of mitomycin C interstrand cross-links. Mol. Cell. Biol. 23:2003;754-761.
9. Collins A.R. Mutant rodent cell lines sensitive to ultraviolet light, ionizing radiation and cross-linking agents: a comprehensive survey of genetic and biochemical characteristics. Mutat. Res. 293:1993;99-118.
10. Li L., Peterson C.A., Lu X., Wei P., Legerski R.J. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol. Cell. Biol. 19:1999;5619-5630.
11. Adair G.M., Rolig R.L., Moore-Faver D., Zabelshansky M., Wilson J.H., Nairn R.S. Role of ERCC1 in removal of long non-homologous tails during targeted homologous recombination. EMBO J. 19:2000;5552-5561.
12. Sargent R.G., Meservy J.L., Perkins B.D., Kilburn A.E., Intody Z., Adair G.M., Nairn R.S., Wilson J.H. Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells. Nucl. Acids Res. 28:2000;3771-3778.
13. Kuraoka I., Kobertz W.R., Ariza R.R., Biggerstaff M., Essigmann J.M., Wood R.D. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275:2000;26632-26636.
14. Marra G., Schar P. Recognition of DNA alterations by the mismatch repair system. Biochem. J. 338:1999;1-13.
15. Guerrette S., Wilson T., Gradia S., Fishel R. Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol. Cell. Biol. 18:1998;6616-6623.
16. Planck M., Wenngren E., Borg A., Olsson H., Nilbert M. Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation. Genes Chromosomes Cancer. 29:2000;33-39.
17. Claij N., Te Riele H. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Oncogene. 21:2002;2873-2879.
18. Zhang H., Richards B., Wilson T., Lloyd M., Cranston A., Thorburn A., Fishel R., Meuth M. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res. 59:1999;3021-3027.
19. Saparbaev M., Prakash L., Prakash S. Requirement of mismatch repair genes MSH2 and MSH3 in the RAD1-RAD10 pathway of mitotic recombination in Saccharomyces cerevisiae. Genetics. 142:1996;727-736.
20. Evans E., Sugawara N., Haber J.E., Alani E. The Saccharomyces cerevisiae Msh2 mismatch repair protein localizes to recombination intermediates in vivo. Mol. Cell. 5:2000;789-799.
21. Bertrand P., Tishkoff D.X., Filosi N., Dasgupta R., Kolodner R.D. Physical interaction between components of DNA mismatch repair and nucleotide excision repair. Proc. Natl. Acad. Sci. 95:1998;14278-14283.
22. Zhang N., Lu X., Zhang X., Peterson C.A., Legerski R.J. hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. Cell. Biol. 22:2002;2388-2397.
23. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
24. Miller H., Grollman A.P. DNA repair investigations using siRNA. DNA Repair. 2:2003;759-763.
25. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
26. Hayashi T., Takao M., Tanaka K., Yasui A. ERCC1 mutations in UV-sensitive Chinese hamster ovary (CHO) cell lines. Mutat. Res. 407:1998;269-276.
27. Mello J.A., Acharya S., Fishel R., Essigmann J.M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:1996;579-589.
28. Mu D., Tursun M., Duckett D.R., Drummond J.T., Modrich P., Sancar A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell. Biol. 17:1997;760-769.
29. Moggs J.G., Szymkowski D.E., Yamada M., Karran P., Wood R.D. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucl. Acids Res. 25:1997;480-491.
30. Fourrier L., Brooks P., Malinge J.M. Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein. J. Biol. Chem. 278:2003;21267-21275.
31. Ichikawa M., Nakane H., Marra G., Corti C., Jiricny J., Fitch M., Ford J.M., Ikejima M., Shimada T., Yoshino M., Takeuchi S., Nakatsu Y., Tanaka K. Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice. Mutat. Res. 459:2000;285-298.
32. Tanaka K., Kamiuchi S., Ren Y., Yonemasu R., Ichikawa M., Murai H., Yoshino M., Takeuchi S., Saijo M., Nakatsu Y., Miyauchi-Hashimoto H., Horio T. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency. Mutat. Res. 477:2001;31-40.
33. Yoshino M., Nakatsu Y., te Riele H., Hirota S., Kitamura Y., Tanaka K. Additive roles of XPA and MSH2 genes in UVB-induced skin tumorigenesis in mice. DNA Repair. 1:2002;935-940.
34. Peters A.C., Young L.C., Maeda T., Tron V.A., Andrew S.E. Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation. DNA Repair (Amsterdam). 2:2003;427-435.
35. de Laat W.L., Sijbers A.M., Odijk H., Jaspers N.G., Hoeijmakers J.H. Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucl. Acids Res. 26:1998;4146-4152.
36. Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers C.J., Nigg A., van Steeg H., Bootsma D., Hoeijmakers J.H. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure. Curr. Biol. 7:1997;427-439.
37. Melton D.W., Ketchen A.M., Nunez F., Bonatti-Abbondandolo S., Abbondandolo A., Squires S., Johnson R.T. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination. J. Cell. Sci. 111:1998;395-404.
38. Zhang N., Zhang X., Peterson C., Li L., Legerski R. Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts. Nucl. Acids Res. 28:2000;4800-4804.
39. Fink D.A., Nebel S., Aebi S., Zheng H., Cenni B., Nehme A., Christen R.D., Howell S.B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56:1996;4881-4886.
40. Vaisman A., Varchenko M., Umar A., Kunkel T.A., Risinger J.I., Barrett J.C., Hamilton T.C., Chaney S.G. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58:1998;3579-3585.
41. Massey A A., Offman J., Macpherson P., Karran P. DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells. DNA Repair (Amsterdam). 2:2003;73-89.
42. Aquilina G., Ceccotti S., Martinelli S., Hampson R., Bignami M. N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 58:1998;135-141.
43. Fiumicino S., Martinelli S., Colussi C., Aquilina G., Leonetti C., Crescenzi M., Bignami M. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repairdefective cells in vitro and in xenografts. Int. J. Cancer. 85:2000;590-596.
44. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939.
45. Bellacosa A. Functional interations and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ. 8:2001;1076-1092.
46. Park C.H., Sancar A. Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins. Proc. Natl. Acad. Sci. 91:1994;5017-5021.
47. Saijo M., Kuraoka I., Masutani C., Hanaoka F., Tanaka K. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro. Nucl. Acids Res. 24:1996;4719-4724.
48. De Silva I.U., McHugh P.J., Clingen P.H., Hartley J.A. Defects in interstrand crosslink uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucl. Acids Res. 30:2002;3848-3856.